Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of CancerReferences
- Creating a language for ‘spiritual pain’ through research: a beginning.Support Care Cancer. 2002; 10: 637-646
- Religious and spiritual resources, CAM, and conventional treatment in the lives of cancer patients.Altern Ther Health Med. 2003; 9: 64-71
- Systematic review of psychological therapies for cancer patients: overview and recommendations for future research.J Natl Cancer Inst. 2002; 94: 558-584
- UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years.Lancet. 2000; 355: 1822
- Lost for words. The mangling and manipulating of the English language. Hodder & Stoughton, London2004
Shorter Oxford English dictionary, third ed. Oxford: Oxford University Press; 1944.
- Janus: a summing up.Picador, London1978
- Psycho-social effect on immune function and disease progression in cancer: human studies.in: Ader C. Felton D. Cohen C. Psychoneuroimmunology. Academic Press, New York2001
American Cancer Society I. An overview of complementary and alternative therapies. Available from: http://www.cancer.org/docroot/ETO/content/ETO_5_1_Introduction.asp.
Cochrane Complementary Medicine Field CAM definition. 2004. Available from: http://www.compmed.umm.edu/compmed/cochrane/cochrane.htm.
Horneber MA, Büschel G, Less DB, Ritter E, Dennert G. The prevalence of unconventional methods in cancer patients: a systematic review. 2006 (in press).
- Possible interactions between dietary antioxidants and chemotherapy.Oncology (Huntingt). 1999; 13 (see comments): 1003-1008
- Potential of chemotherapy-herb interactions in adult cancer patients.Support Care Cancer. 2004; 12: 454-462
- Herbal remedies in the United States: potential adverse interactions with anticancer agents.J Clin Oncol. 2004; 22: 2489-2503
- Potential health risks of complementary alternative medicines in cancer patients.Br J Cancer. 2004; 90: 408-413
- Health food store recommendations: implications for breast cancer patients.Breast Cancer Res. 2003; 5: R170-R174
- Use of complementary/integrative nutritional therapies during cancer treatment: implications in clinical practice.Cancer Control. 2002; 9: 236-243
- Interactions between herbal medicines and prescribed drugs: a systematic review.Drugs. 2001; 61: 2163-2175
- Beyond convention: describing complementary therapy use by women living with breast cancer.Patient Educ Couns. 1999; 38: 143-153
- Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives.Psycho Oncology. 2002; 11: 212-220
- How to improve communication between physicians and cancer patients about use of complementary and alternative medicine?.Psycho Oncology. 2003; 12: 203-204
- Unkonventionelle Verfahren – Chancen für die Arzt-Patient-Beziehung (Unconventional methods. Chances for the physician-patient relationship).Onkologe. 2003; 9: 1335-1342
- Advising patients who seek complementary and alternative medical therapies for cancer.Ann Intern Med. 2002; 137: 889-903
- Advising inquirers about unconventional cancer therapies.Onkologie. 1999; 22: 238
- Factors affecting patient and clinician satisfaction with the clinical consulation: can communication skills training for clinicians improve satisfaction?.Psycho Oncology. 2003; 12: 599-611
- Enduring impact of communication skills training: results of a 12-month follow-up.Br J Cancer. 2003; 89: 1445-1449
- Evaluation of quality of life in patients receiving treatment for advanced breast cancer.Lancet. 1976; 1: 899-900
- The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT).Eur J Cancer. 2000; 36: 2090-2095
- A comparison of conventional and alternative practitioners’ views of the communication process in cancer care.Psycho Oncology. 1999; 8: 11
- A strategy for informing patients and health professionals about unconventional cancer therapies.J Cancer Educ. 1998; 13: 31-38
- Treatment seeking and experience with complementary/alternative medicine: a continuum of choice.J Altern Complement Med. 2002; 8: 127-134
- An investigation of the health beliefs and motivations of complementary medicine clients.Soc Sci Med. 2002; 55: 1025-1037
- The patient’s motivation in seeking complementary therapies.Patient Educ Couns. 1999; 38: 161-165
- Decision making related to complementary therapies: a process of regaining control.Patient Educ Couns. 1999; 38: 131-142
- Health beliefs and alternative medicine: a qualitative study of breast cancer patients.J Cancer Educ. 1996; 11: 226-229
- Why do patients turn to complementary medicine? An empirical study.Br J Clin Psychol. 1996; 35: 37-48
- Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents.Psychooncology. 2005; 14: 135-146
- A short history of breast cancer.Springer, Dordrecht1989
- Spontaneous regression of breast cancer.Natl Cancer Inst Monogr. 1976; 44: 23-26
- Spontaneous regression of breast carcinoma: follow-up report and literature review.J Surg Oncol. 1982; 19: 22-24
- The expanded version of the Functional Assessment of Chronic Illness Therapy – Spiritual Well-Being Scale (FACIT-Sp-Ex): Initial report of psychometric properties.Ann Behav Med. 1999; 21: 129
- Addressing spiritual care: calling for help.J Clin Oncol. 2004; 22: 4856-4858
- How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?.Br J Cancer. 2001; 84: 179-185
- Religious commitment and health status: a review of the research and implications for family medicine.Arch Fam Med. 1998; 7: 118-124
The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995;41(10):1403–1409.
- Cost effectiveness of complementary treatments in the United Kingdom: systematic review.Br Med J. 2005; 331: 880-881
Ernst E, Schmidt K, Baum M. Complementary/alternative therapies for the treatment of breast cancer. A systematic review of randomised clinical trials and critique of current terminology. 2005 (in press).
- [Randomized study: chemotherapy versus chemotherapy plus transfer factor in metastasized breast neoplasm].Verh Dtsch Ges Inn Med. 1978; 84: 604-606
- Remissionserhaltung nicht-metastasierter Mammakarzinome unter Factor AF2.Dtsch Zschr Onkol. 1989; 21: 102-104
- Effect of Psychosocial Treatment on Survival of Patients with Metastatic Breast Cancer.Lancet. 1989; 14: 888-891
- Supporting therapy with Shi Quan Da Bu Tang in advanced breast cancer patients.Biomed Res. 1990; 11: 25-32
- Fluorouracil (F), with and without high-dose folinic acid (HDFA) plus Epirubicin (E) and Cyclophosphamide (C): FEC versus HDFA-FEC plus or minus Thymostimulin (TS) in metastatic breast cancer: results of a multicenter study.Eur J Cancer. 1993; 29 A: S77
- A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.Br J Cancer. 1994; 69: 196-199
- A randomised controlled trial of psychotherapeutic intervention in cancer patients.Ann RCPSC. 1994; 27: 93-96
- A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer.Psycho Oncology. 1998; 7: 508-517
- Effects of group CBT on the survival time of patients with metastatic breast cancer.Psychooncology. 1999; 8: 474-481
- Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status.Eur J Cancer. 1999; 35: 1688-1692
- Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy.Br J Cancer. 1999; 80: 262-268
- The effect of group psychosocial support on survival in metastatic breast cancer.N Engl J Med. 2001; 345: 1719-1726
- Effect of cognitive-existential group therapy on survival in early-stage breast cancer.J Clin Oncol. 2004; 22: 4255-4260
- Assessing the quality of reports of randomized clinical trials: is blinding necessary?.Control Clin Trials. 1996; 17: 1-12
- Can acupuncture have specific effects on health? A systematic review of acupuncture antiemesis trials.J R Soc Med. 1996; 89: 303-311
- The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial.Support Care Cancer. 2002; 10: 237-246
- A Phase I–II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy.Int J Radiat Oncol Biol Phys. 2003; 57: 472-480
- An evaluation of aromatherapy massage in palliative care.Palliat Med. 1999; 13: 409-417
- The role of aromatherapy massage in reducing anxiety in patients with malignant brain tumours.Int J Palliat Nurs. 2001; 7: 279-285
- A systematic review of guided imagery as an adjuvant cancer therapy.Psychooncology. 2005; 14: 607-617
- The desktop guide to complementary and alternative medicine an evidence-based approach.C.V. Mosby, Edinburgh2001
- Efficacy of progressive muscle relaxation training and guided imagery in reducing chemotherapy side effects in patients with breast cancer and in improving their quality of life.Support Care Cancer. 2005; 13: 826-833
- Exercise manages fatigue during breast cancer treatment: A randomized controlled trial.Psychooncology. 2005; 14: 464-477
- Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer.J Clin Oncol. 2004; 22: 1447-1453
- The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial.Anticancer Res. 2004; 24: 1293-1302